Researcher.Life Logo

Tumour Virus Research : Impact Factor & More

eISSN: 2666-6790pISSN: 2666-6790
JournalOpen Access

Key Metrics

CiteScore
8.3
SJR
Q2Virology
SNIP
1.44
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Tumour Virus Research

Tumour Virus Research Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • DOAJ DOAJ
  • SJR SJR
Overview
Publisher ELSEVIER
Language English
Frequency Continuous publication
Article Processing ChargesUSD 900
Publication Time14
Editorial Review ProcessAnonymous peer review
General Details
LanguageEnglish
FrequencyContinuous publication
Publisher URLVisit website
Website URLVisit website
Publication Details
PlagiarismVisit website
Publication Time 14
Waiver PolicyVisit website
Editorial Review Detail
Editorial TeamVisit website
Review ProcessAnonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Copyright DetailsVisit website
License typeCC BY, CC BY-NC-ND
OA statementVisit website
View less

Planning to publish in Tumour Virus Research ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Tumour Virus Research

30-hydroxygambogic acid activates overlapping and independent apoptotic pathways in HPV positive and HPV negative oral cancer cells.
  • 1 Jun 2026
  • Tumour virus research
HPV18E6 and CDK5 virus-host interaction is a prospective therapeutic target for HPV-positive cervical cancer.
  • 1 Jun 2026
  • Tumour virus research
Oncolytic virus hijacks GOT1 and pyrimidinosomes to fuel pyrimidine synthesis for replication in tumor cells.
  • 1 Jun 2026
  • Tumour virus research
Susceptibility of naturally human papillomavirus type 16 major capsid protein L1 variants to vaccines and predictions of future evolutionary trends.
  • 1 Jun 2026
  • Tumour virus research
PRMT5–mediated symmetric dimethylation of SHBs at Arg169 stabilizes SHBs and promotes angiogenesis and tumor growth
  • 26 Mar 2026
  • Tumour Virus Research
Ad-VT oncolytic adenovirus suppresses bladder cancer via cAMP-dependent AMPK-Raptor activation and G2/M arrest
  • 29 Jan 2026
  • Tumour Virus Research
30-hydroxygambogic acid activates overlapping and independent apoptotic pathways in HPV positive and HPV negative oral cancer cells.
  • 1 Jun 2026
  • Tumour virus research
HPV18E6 and CDK5 virus-host interaction is a prospective therapeutic target for HPV-positive cervical cancer.
  • 1 Jun 2026
  • Tumour virus research
Oncolytic virus hijacks GOT1 and pyrimidinosomes to fuel pyrimidine synthesis for replication in tumor cells.
  • 1 Jun 2026
  • Tumour virus research
Susceptibility of naturally human papillomavirus type 16 major capsid protein L1 variants to vaccines and predictions of future evolutionary trends.
  • 1 Jun 2026
  • Tumour virus research
PRMT5–mediated symmetric dimethylation of SHBs at Arg169 stabilizes SHBs and promotes angiogenesis and tumor growth
  • 26 Mar 2026
  • Tumour Virus Research
Ad-VT oncolytic adenovirus suppresses bladder cancer via cAMP-dependent AMPK-Raptor activation and G2/M arrest
  • 29 Jan 2026
  • Tumour Virus Research

FAQs on Tumour Virus Research